Video

Ted Okon Talks About the Issues With Reimbursement

Author(s):

Ted Okon

Ted Okon Talks About the Issues With Reimbursement

Ted Okon the Executive Director of the Community Oncology Alliance (COA) Talks About the Issues With Reimbursement

Related Videos
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Howard S. Hochster, MD, FACP,
John H. Strickler, MD
Brandon G. Smaglo, MD, FACP
Cedric Pobel, MD
Ruth M. O’Regan, MD
Michael R. Grunwald, MD, FACP
Peter Forsyth, MD
John N. Allan, MD
Dr Dorritie on the Clinical Implications of the 5-Year Follow-Up Data From CAPTIVATE in CLL/SLL
Related Content
Jairam Krishnamurthy, MD, FACP
November 22nd 2024

Category 1 Recommendation of Ribociclib Plus an AI Represents Huge Advancement in Breast Cancer

Sorting Through Sexism, Guilt, and Motherhood in Medicine
January 27th 2022

Sorting Through Sexism, Guilt, and Motherhood in Medicine

Jeff Patton, MD
September 24th 2024

Medicare Drug Price Negotiations Will Have Domino Effect for Community Oncology Practices

Gilbert on Gaining New Ground at Vanderbilt
January 3rd 2022

Gilbert on Gaining New Ground at Vanderbilt

Debra Patt, MD, PhD, MBA, FASCO, of Texas Oncology
September 5th 2024

Medicare Drug Price Negotiation Program Will Result in Financial Burdens for Community Oncology Practices

Jeff Patton, MD
September 4th 2024

A Decrease in Innovation Is a Large Concern With New IRA Policies in Oncology